Search results
Potential Precursor Lesion to Adrenal Tumors Identified
Medscape· 2 days agoCortisol-producing adenomas (CPAs) are preceded by the development of steroids-producing nodules...
Guselkumab Continues Winning Streak in Crohn's Disease
MedPage Today· 3 days agoInduction and maintenance treatment with guselkumab (Tremfya) demonstrated its safety and efficacy...
Research shows linked biological pathways driving skin inflammation
Medical Xpress· 4 days agoInflammation is the body's natural response to irritation and infection, but when out of control, it...
Alvotech (ALVO) Scheduled to Post Quarterly Earnings on Tuesday
ETF DAILY NEWS· 6 days agoAlvotech (NYSE:ALVO – Get Free Report) will post its quarterly earnings results after the market closes on Tuesday, May 21st. Individual interested in participating in the company’s earnings ...
Amgen Inc. (NASDAQ:AMGN) Holdings Cut by Panagora Asset Management Inc.
ETF DAILY NEWS· 5 days agoPanagora Asset Management Inc. decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.1% in the fourth quarter, according to the company in its most recent disclosure ...
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
InvestorPlace· 5 days agoFundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 5 days agoWASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...
Marathon Capital Management Has $4.48 Million Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 5 days agoMarathon Capital Management grew its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.6% during the fourth quarter, according to the company in its most recent disclosure with ...
AbbVie (NYSE:ABBV) Now Covered by Cantor Fitzgerald
ETF DAILY NEWS· 6 days agoCantor Fitzgerald assumed coverage on shares of AbbVie (NYSE:ABBV – Get Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. Cantor Fitzgerald’s price objective ...
Johnson & Johnson (NYSE:JNJ) Stock Rating Reaffirmed by Royal Bank of Canada
ETF DAILY NEWS· 1 day agoJohnson & Johnson (NYSE:JNJ – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at Royal Bank of Canada in a report issued on Wednesday, Benzinga reports.